Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory for Reproductive Medicine of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
J Ovarian Res. 2022 Sep 8;15(1):101. doi: 10.1186/s13048-022-01035-8.
In this study, we aimed to evaluate the impact of the duration of cryopreservation storage on embryo viability, implantation competence, pregnancy outcome and neonatal outcomes.
We retrospectively evaluated the outcomes of patients who underwent IVF with vitrified cryopreserved embryos between January 2004 and August 2019 by following the first frozen embryo transfer cycles within the study period. A total of 31,143 patients met the inclusion criteria and were grouped according to the embryo storage time as follows: Group 1 (n = 20,926),1-90 days; Group 2 (n = 6,472), 91-180 days; Group 3 (n = 2,237), 181-365 days; Group 4 (n = 746), 366-730 days; and Group 5 (n = 762), > 731 days.
The embryo survival rate decreased significantly with longer durations of cryopreservation. The highest and lowest survival rate was recorded in Group 1 and Group 5, respectively (34853/35338; 98.63% vs. 1281/1801; 71.13%; P < 0.01). The human chorionic gonadotropin (HCG) detection and clinical pregnancy rate was highest in Group 1 (57.85% and 55. 26%, respectively; P < 0.01). Short-term cryopreservation (≤ 3 months) is associated with higher rates of clinical pregnancy. There were no significant differences in neonatal birth weight, neonatal height and congenital anomalies among the groups (P > 0. 05).
The prolonged storage time of vitrified embryos negatively affected survival rate and clinical pregnancy rate. It did not have a significant influence on neonatal health. This study provides new findings about the relationship between prolonged storage time of vitrified embryos and clinical outcomes and offers evidence for the safety of using long-stored embryos after vitrification.
本研究旨在评估胚胎冷冻保存时间对胚胎活力、着床能力、妊娠结局和新生儿结局的影响。
我们回顾性评估了 2004 年 1 月至 2019 年 8 月期间进行玻璃化冷冻胚胎复苏移植周期的患者的结局。共有 31143 例患者符合纳入标准,并根据胚胎储存时间分为以下几组:第 1 组(n=20926),1-90 天;第 2 组(n=6472),91-180 天;第 3 组(n=2237),181-365 天;第 4 组(n=746),366-730 天;第 5 组(n=762),>731 天。
胚胎存活率随冷冻保存时间的延长而显著下降。存活率最高和最低的分别是第 1 组和第 5 组(34853/35338;98.63% vs. 1281/1801;71.13%;P<0.01)。第 1 组 hCG 检测阳性率和临床妊娠率最高(分别为 57.85%和 55.26%;P<0.01)。短期冷冻保存(≤3 个月)与较高的临床妊娠率相关。各组新生儿出生体重、身高和先天畸形无显著差异(P>0.05)。
玻璃化冷冻胚胎储存时间延长会降低胚胎存活率和临床妊娠率,但对新生儿健康无显著影响。本研究提供了关于玻璃化冷冻胚胎储存时间与临床结局关系的新发现,为玻璃化冷冻后使用长期储存胚胎的安全性提供了证据。